Jul 31, 2026 10:12AM
Jul 31, 2026 10:12AM
Jul 31, 2026 08:10AM
Jul 31, 2026 08:10AM
Jul 6, 2026 08:33AM
Jul 6, 2026 08:33AM
Jul 6, 2026 08:33AM Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor "What This Means" Segment
Jun 30, 2026 08:30AM
Jun 30, 2026 08:30AM
Jun 5, 2026 08:29AM
Jun 5, 2026 08:29AM
Jun 4, 2026 08:31AM
May 29, 2026 08:21AM
May 21, 2026 05:02PM Moleculin presents cardiac safety data for Annamycin at 2026 ASCO meeting
May 21, 2026 05:02PM
May 15, 2026 08:30AM
May 13, 2026 08:03AM
May 13, 2026 08:00AM
May 12, 2026 09:30AM
May 12, 2026 09:30AM
May 12, 2026 09:30AM Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits
May 8, 2026 08:45AM
May 8, 2026 08:45AM
Apr 23, 2026 08:27AM
Apr 23, 2026 08:25AM
Apr 21, 2026 08:36AM
Apr 7, 2026 12:52PM
Apr 7, 2026 08:42AM Moleculin highlights Annamycin's non-cardiotoxic profile in CEO segment
Apr 7, 2026 08:36AM
Apr 7, 2026 08:36AM
Mar 23, 2026 08:33AM
Mar 23, 2026 08:31AM
Mar 23, 2026 08:31AM
Mar 19, 2026 08:36AM
Mar 17, 2026 09:05AM Moleculin to Present at 38th Annual ROTH Conference
Mar 11, 2026 09:00AM
Mar 11, 2026 09:00AM
Feb 19, 2026 08:39AM
Feb 19, 2026 08:39AM
Feb 18, 2026 08:20AM
Feb 18, 2026 08:20AM
Feb 17, 2026 08:35AM Moleculin receives Japanese patent allowance for Annamycin formulation
Feb 17, 2026 08:35AM
Feb 13, 2026 08:35AM
Feb 13, 2026 08:32AM
Feb 5, 2026 09:15AM
Jan 13, 2026 08:55AM
Jan 13, 2026 08:55AM
Jan 12, 2026 08:37AM Moleculin expects first pivotal trial data readout in Q1 2026
Jan 12, 2026 08:36AM

327,059 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All